scholarly article | Q13442814 |
P2093 | author name string | Ming Li | |
James R Goldenring | |||
Bing Zhang | |||
Daniel C Liebler | |||
Han-Kwang Yang | |||
Woo Ho Kim | |||
Hyuk-Joon Lee | |||
Amy-Joan L Ham | |||
Ki Taek Nam | |||
Bonnie LaFleur | |||
Corbin Whitwell | |||
Josane F Sousa | |||
P2860 | cites work | DMBT1, a regulator of mucosal homeostasis through the linking of mucosal defense and regeneration? | Q24299484 |
Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software | Q24622701 | ||
The origin of pre-neoplastic metaplasia in the stomach: chief cells emerge from the Mist | Q24630749 | ||
Mature chief cells are cryptic progenitors for metaplasia in the stomach | Q24631089 | ||
MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis | Q24657366 | ||
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors | Q28282622 | ||
A model for random sampling and estimation of relative protein abundance in shotgun proteomics | Q29547316 | ||
Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications | Q31059425 | ||
Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression | Q33200793 | ||
A molecular signature of gastric metaplasia arising in response to acute parietal cell loss | Q33317849 | ||
Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens | Q33414848 | ||
Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer | Q33557996 | ||
Proteomic parsimony through bipartite graph analysis improves accuracy and transparency | Q33607604 | ||
Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling. | Q33619625 | ||
Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. | Q33667106 | ||
Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia | Q33750475 | ||
Pathology of gastric intestinal metaplasia: clinical implications | Q33954445 | ||
The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. | Q34087033 | ||
Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. | Q34105844 | ||
Multifunctional roles of lactoferrin: a critical overview | Q34464216 | ||
Acid incubation reverses the polarity of intercalated cell transporters, an effect mediated by hensin | Q34786372 | ||
Development and evaluation of a micro- and nanoscale proteomic sample preparation method | Q35610009 | ||
The gastric precancerous cascade | Q36115055 | ||
Immobilized pH gradient isoelectric focusing as a first-dimension separation in shotgun proteomics | Q36388729 | ||
Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within | Q36519169 | ||
Non-parametric trend tests for learning data | Q36564686 | ||
Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia | Q36647595 | ||
Differentiation of columnar epithelia: the hensin pathway. | Q36665961 | ||
Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes | Q36743192 | ||
Carcinogenesis of Helicobacter pylori | Q36903152 | ||
Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. | Q37294434 | ||
The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer | Q37448891 | ||
Current understanding of SPEM and its standing in the preneoplastic process | Q37666872 | ||
Lactoferrin: the path from protein to gene | Q37707187 | ||
Oxyntic atrophy, metaplasia, and gastric cancer | Q37809358 | ||
Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade | Q38336452 | ||
Comparison of stable-isotope labeling with amino acids in cell culture and spectral counting for relative quantification of protein expression. | Q39494662 | ||
A human model of gastric carcinogenesis. | Q39644851 | ||
Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer | Q39651684 | ||
Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis | Q39978484 | ||
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy | Q40180989 | ||
Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer. | Q40448019 | ||
Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer | Q40959040 | ||
Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer. | Q41861115 | ||
Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer. | Q42439199 | ||
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity | Q44028747 | ||
Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column | Q44079243 | ||
Comparison of label-free methods for quantifying human proteins by shotgun proteomics. | Q46568113 | ||
DMBT1 is frequently downregulated in well-differentiated gastric carcinoma but more frequently upregulated across various gastric cancer types | Q48175271 | ||
Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. | Q50508280 | ||
Cell lineage dynamics in the process leading to intestinal metaplasia. | Q53262771 | ||
Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. | Q54469747 | ||
Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. | Q54650767 | ||
Expression of hGC-1 is correlated with differentiation of gastric carcinoma. | Q55044225 | ||
An integrative model on the role of DMBT1 in epithelial cancer | Q57326183 | ||
Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori | Q79837317 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 1560-1572 | |
P577 | publication date | 2012-09-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers | |
P478 | volume | 181 |
Q37537123 | Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers |
Q91739457 | An LCM-based genomic analysis of SPEM, Gastric Cancer and Pyloric Gland Adenoma in an Asian cohort |
Q34045410 | Autoimmune gastritis: Pathologist's viewpoint |
Q26784448 | Challenges of deciphering gastric cancer heterogeneity |
Q40694864 | Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori |
Q91886286 | Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury |
Q33688456 | Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics |
Q37741814 | Distinct metaplastic and inflammatory phenotypes in autoimmune and adenocarcinoma-associated chronic atrophic gastritis |
Q38200653 | Divide and conquer: subproteomic approaches toward gastric cancer biomarker and drug target discovery |
Q38820714 | Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer |
Q38830215 | Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies. |
Q38435624 | Introducing crucial protein panel of gastric adenocarcinoma disease |
Q35742217 | Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer |
Q48028364 | Maturity and age influence chief cell ability to transdifferentiate into metaplasia |
Q41239086 | Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy |
Q37594950 | Murine Models of Gastric Corpus Preneoplasia. |
Q27012898 | Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications |
Q38981782 | Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics |
Q35845797 | Progress in the development of protein biomarkers of oesophageal and gastric cancers |
Q54962725 | Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics. |
Q38975703 | Proteomics approach to identify biomarkers for upper gastrointestinal cancer. |
Q38942781 | Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells |
Q58802540 | Residual tissue repositories as a resource for population-based cancer proteomic studies |
Q28541808 | SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin |
Q30235387 | The role of antiangiogenic agents in the treatment of gastric cancer: A systematic review and meta-analysis |
Q64929421 | Use of ANGPTL2 mRNA levels in formalin-fixed paraffin-embedded tissues as a biomarker to diagnose gastric cancer and to evaluate the extent of vascular invasion. |
Q34468252 | miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach |
Search more.